Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Journal of the American Society of Nephrology : JASN
|
November 21, 2008
Induction of T regulatory cells attenuates idiopathic nephrotic syndrome
Ludmilla Le Berre, Sarah Bruneau, Jeanne Naulet, et al.
Journal of Leukocyte Biology
|
May 27, 2010
Tmem176B and Tmem176A are associated with the immature state of dendritic cells
Thomas Condamine, Laetitia Le Texier, Duncan Howie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 15, 2016
Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
George A Dominguez, Thomas Condamine, Sridevi Mony, et al.
Nature Immunology
|
January 29, 2013
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
Je-In Youn, Vinit Kumar, Michelle Collazo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 21, 2014
Oxidized lipids block antigen cross-presentation by dendritic cells in cancer
Rupal Ramakrishnan, Vladimir A Tyurin, Vladimir A Tuyrin, et al.
The Journal of Experimental Medicine
|
February 11, 2015
Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells
Myrna L Ortiz, Vinit Kumar, Anna Martner, et al.
The Journal of Experimental Medicine
|
September 30, 2010
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A Corzo, Thomas Condamine, Lily Lu, et al.
Immunity
|
February 18, 2016
CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
Vinit Kumar, Pingyan Cheng, Thomas Condamine, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
Elizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, et al.
The Journal of Clinical Investigation
|
May 3, 2014
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis
Thomas Condamine, Vinit Kumar, Indu R Ramachandran, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Journal of the American Society of Nephrology : JASN
|
November 21, 2008
Induction of T regulatory cells attenuates idiopathic nephrotic syndrome
Ludmilla Le Berre, Sarah Bruneau, Jeanne Naulet, et al.
Journal of Leukocyte Biology
|
May 27, 2010
Tmem176B and Tmem176A are associated with the immature state of dendritic cells
Thomas Condamine, Laetitia Le Texier, Duncan Howie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 15, 2016
Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
George A Dominguez, Thomas Condamine, Sridevi Mony, et al.
Nature Immunology
|
January 29, 2013
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
Je-In Youn, Vinit Kumar, Michelle Collazo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 21, 2014
Oxidized lipids block antigen cross-presentation by dendritic cells in cancer
Rupal Ramakrishnan, Vladimir A Tyurin, Vladimir A Tuyrin, et al.
The Journal of Experimental Medicine
|
February 11, 2015
Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells
Myrna L Ortiz, Vinit Kumar, Anna Martner, et al.
The Journal of Experimental Medicine
|
September 30, 2010
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A Corzo, Thomas Condamine, Lily Lu, et al.
Immunity
|
February 18, 2016
CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
Vinit Kumar, Pingyan Cheng, Thomas Condamine, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
Elizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, et al.
The Journal of Clinical Investigation
|
May 3, 2014
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis
Thomas Condamine, Vinit Kumar, Indu R Ramachandran, et al.
Page
of 3